Jonathan Hazlehurst

4.2k total citations · 3 hit papers
43 papers, 3.1k citations indexed

About

Jonathan Hazlehurst is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Jonathan Hazlehurst has authored 43 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in Jonathan Hazlehurst's work include Liver Disease Diagnosis and Treatment (13 papers), Bariatric Surgery and Outcomes (7 papers) and Hormonal Regulation and Hypertension (6 papers). Jonathan Hazlehurst is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Bariatric Surgery and Outcomes (7 papers) and Hormonal Regulation and Hypertension (6 papers). Jonathan Hazlehurst collaborates with scholars based in United Kingdom, Ireland and United States. Jonathan Hazlehurst's co-authors include Jeremy Tomlinson, Matthew J. Armstrong, Philip N. Newsome, Stephen Gough, Diana Hull, Darren Barton, Kathy Guo, Richard Parker, Rachel M. Brown and Stefan G. Hübscher and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jonathan Hazlehurst

40 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

2015 1.6k citations Matthew J. Armstrong, Piers Gaunt et al. The Lancet profile →
Non-alcoholic fatty liver disease and diabetes

2016 403 citations Jonathan Hazlehurst, Conor Woods et al. Metabolism profile →
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

2015 351 citations Matthew J. Armstrong, Diana Hull et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Hazlehurst United Kingdom	19	2.2k	1.8k	654	642	555	43	3.1k
Ilaria Barchetta Italy	25	982 0.5×	524 0.3×	333 0.5×	415 0.6×	182 0.3×	72	2.1k
Winston Dunn United States	19	1.8k 0.8×	831 0.5×	290 0.4×	283 0.4×	757 1.4×	42	2.4k
Benjamin Bouillet France	24	793 0.4×	966 0.5×	310 0.5×	567 0.9×	181 0.3×	95	1.8k
Kap Bum Huh South Korea	26	940 0.4×	1.1k 0.6×	312 0.5×	356 0.6×	136 0.2×	119	2.4k
Mark Jaros United States	17	723 0.3×	567 0.3×	725 1.1×	1.6k 2.5×	293 0.5×	50	3.1k
Cristina Maglio Sweden	18	645 0.3×	616 0.3×	188 0.3×	871 1.4×	131 0.2×	41	1.8k
Hazem Elariny United States	18	1.1k 0.5×	461 0.3×	229 0.4×	298 0.5×	308 0.6×	26	1.5k
Shinae Kang South Korea	25	659 0.3×	708 0.4×	512 0.8×	417 0.6×	116 0.2×	74	2.4k
Carlo Pirazzi Sweden	16	550 0.3×	570 0.3×	195 0.3×	679 1.1×	137 0.2×	29	1.5k
Elena Succurro Italy	29	711 0.3×	1.5k 0.9×	743 1.1×	371 0.6×	70 0.1×	133	2.9k

Countries citing papers authored by Jonathan Hazlehurst

Since Specialization

Citations

This map shows the geographic impact of Jonathan Hazlehurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Hazlehurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Hazlehurst more than expected).

Fields of papers citing papers by Jonathan Hazlehurst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Hazlehurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Hazlehurst. The network helps show where Jonathan Hazlehurst may publish in the future.

Co-authorship network of co-authors of Jonathan Hazlehurst

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Hazlehurst. A scholar is included among the top collaborators of Jonathan Hazlehurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Hazlehurst. Jonathan Hazlehurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sousa, Berta, Pushpa Singh, Sally Abbott, et al.. (2025). Variation in the commissioning of specialist weight management services and bariatric surgery across England: Results of a freedom of information‐based mapping exercise across the 42 integrated Care Systems of England. Clinical Obesity. 15(3). e12731–e12731. 1 indexed citations

Pofi, Riccardo, Thomas Marjot, Amy Barrett, et al.. (2025). Dose-dependent and tissue-specific adverse effects of exogenous glucocorticoids: insights for optimizing clinical practice. Journal of Endocrinological Investigation. 48(9). 2067–2076.

Wang, Zhaonan, Francesca L. Crowe, Abd A. Tahrani, et al.. (2024). The effect of bariatric surgery on diabetes related foot complications among patients with type 2 diabetes: A systematic review. Journal of Diabetes and its Complications. 38(9). 108813–108813. 2 indexed citations

Hazlehurst, Jonathan, Bernard Khoo, Sally Abbott, et al.. (2024). Society for Endocrinology guidelines for the diagnosis and management of post-bariatric hypoglycaemia. Endocrine Connections. 13(5). 12 indexed citations

Phillips, Katherine W., Jonathan Hazlehurst, Srikanth Bellary, et al.. (2023). Inequalities in the management of diabetic kidney disease in UK primary care: A cross‐sectional analysis of a large primary care database. Diabetic Medicine. 41(1). e15153–e15153. 5 indexed citations

Hazlehurst, Jonathan, et al.. (2022). How to manage weight loss in women with obesity and PCOS seeking fertility?. Clinical Endocrinology. 97(2). 208–216. 19 indexed citations

Hazlehurst, Jonathan, Catriona Charlton, Jack J. Miller, et al.. (2022). Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents. SHILAP Revista de lepidopterología. 14. 100177–100177. 9 indexed citations

Wang, Zhaonan, Jonathan Hazlehurst, Anuradhaa Subramanian, et al.. (2022). Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study. Frontiers in Endocrinology. 13. 888924–888924. 5 indexed citations

Coomar, Dyuti, Jonathan Hazlehurst, Charlie Foster, et al.. (2021). Diet and physical activity in pregnancy to prevent gestational diabetes: a protocol for an individual participant data (IPD) meta-analysis on the differential effects of interventions with economic evaluation. BMJ Open. 11(6). e048119–e048119. 3 indexed citations

10.

Torlińska, Barbara, Jonathan Hazlehurst, Krishnarajah Nirantharakumar, et al.. (2021). wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD–HES linked cohort study. BMJ Open. 11(10). e055219–e055219.

11.

Todorčević, Marijana, Ari Manuel, Zoi Michailidou, et al.. (2021). Markers of adipose tissue hypoxia are elevated in subcutaneous adipose tissue of severely obese patients with obesity hypoventilation syndrome but not in the moderately obese. International Journal of Obesity. 45(7). 1618–1622. 22 indexed citations

12.

Marjot, Thomas, Conor Woods, Jonathan Hazlehurst, et al.. (2020). Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids. The Journal of Clinical Endocrinology & Metabolism. 105(9). e3316–e3328. 8 indexed citations

13.

Hazlehurst, Jonathan, Jennifer Logue, Helen M. Parretti, et al.. (2020). Developing Integrated Clinical Pathways for the Management of Clinically Severe Adult Obesity: a Critique of NHS England Policy. Current Obesity Reports. 9(4). 530–543. 34 indexed citations

14.

Hazlehurst, Jonathan, Conor Woods, Thomas Marjot, Jeremy Cobbold, & Jeremy Tomlinson. (2016). Non-alcoholic fatty liver disease and diabetes. Metabolism. 65(8). 1096–1108. 403 indexed citations breakdown →

15.

Crowley, Rachel, Michael O’Reilly, Iwona Bujalska, et al.. (2016). SFRP2 Is Associated with Increased Adiposity and VEGF Expression. PLoS ONE. 11(9). e0163777–e0163777. 26 indexed citations

16.

Armstrong, Matthew J., Piers Gaunt, Guruprasad P. Aithal, et al.. (2015). Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. The Lancet. 387(10019). 679–690. 1554 indexed citations breakdown →

17.

Hazlehurst, Jonathan, et al.. (2015). Compliance with established guidelines for the radiological reporting of atypical femoral fractures. British Journal of Radiology. 89(1057). 20150443–20150443. 14 indexed citations

18.

Armstrong, Matthew J., Jonathan Hazlehurst, Richard Parker, et al.. (2013). Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management. QJM. 107(1). 33–41. 34 indexed citations

19.

Hazlehurst, Jonathan, Laura Gathercole, Maryam Nasiri, et al.. (2013). Glucocorticoids Fail to Cause Insulin Resistance in Human Subcutaneous Adipose Tissue In Vivo. The Journal of Clinical Endocrinology & Metabolism. 98(4). 1631–1640. 51 indexed citations

20.

Cader, M. Zaeem, Andrew Filer, Jonathan Hazlehurst, et al.. (2011). Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Annals of the Rheumatic Diseases. 70(6). 949–955. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact